Hyperhomocysteinemia and risk of cognitive decline: A meta-analysis of prospective cohort studies

European Neurology

Volumn 72, Issue , 2014, Pages 241-248

  Nie, Tian ^a   Lu, Ting ^b   Xie, Lu ^b   Huang, Panpan ^a,b   Lu, Yuan ^a,b   Jiang, Minhai ^a  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cognitive decline; Dementia; Hyperhomocysteinemia; Meta analysis; Prospective cohort studies

Indexed keywords

HOMOCYSTEINE; VITAMIN B GROUP;

ALZHEIMER DISEASE; AMERICAN; ARTICLE; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; EUROPEAN; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; MENTAL DETERIORATION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; AGED; BIBLIOGRAPHIC DATABASE; COGNITION DISORDERS; COMPLICATION; FEMALE; MALE; META ANALYSIS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; COHORT STUDIES; DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; RISK ASSESSMENT; RISK FACTORS;

EID: 84910060881     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000363054     Document Type: Article

References (28)

1. Stead LM, Jacobs RL, Brosnan ME, Brosman JT: Methylation demand and homocysteine metabolism. Adv Enzyme Regul 2004; 44: 321-333.
2. Zylberstein DE, Lissner L, Bjorkelund C, Mehlig K, Thelle DS, Gustafson D, Ostling S, Waern M, Guo X, Skoog I: Midlife homocysteine and late-life dementia in women: a prospective population study. Neurobiol Aging 2009; 32: 380-386.
3. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, Nygaard HA, Smith AD: Plasma total homocysteine and memory in the elderly: the Hordaland homocysteine study. Ann Neurol 2005; 58: 847-857.
4. Whalley LJ, Duthie SJ, Collins AR, Starr JM, Deary IJ, Lemmon H, Duthie AC, Murray AD, Staff RT: Homocysteine, antioxidant micronutrients and late onset dementia. Eur J Nutr 2014;53:277-285.
5. Kim J, Park MH, Kim E, Han C, Jo SA, Jo I: Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. J Nutr 2007; 137: 2093-2097.
6. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM: Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 1999; 150: 283-289.
7. Hooshmand B, Solomon A, Kåreholt I, Rusanen M, Hanninen T, Leiviskä J, Winblad B, Laatikainen T, Soininen H, Kivipelto M: Association between serum homocysteine, holo-transcobalamin, folate and cognition in the elderly: a longitudinal study. J Intern Med 2012; 271: 204-212.
8. Ho RCM, Cheung MWL, Fu E, Win HH, Zaw MH, Ng A, Mak A: Is high homocysteine level a risk factor for cognitive decline in elderly? A systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry 2011; 19: 607-617.
9. Wells G, Shea B, O'Connell D, Peterson J, Welch J, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [EB/OL], 2013, http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
10. Annerbo S, Kivipelto M, Lokk J: A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine. Dement Geriatr Cogn Disord 2009; 28: 275-280.
11. Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, Mariani E, Licastro F, Patterson C: Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol Aging 2007; 28: 1810-1820.
12. Reitz C, Tang MX, Miller J, Green R, Luchsinger JA: Plasma homocysteine and risk of mild cognitive impairment. Dement Geriatr Cogn Disord 2009; 27: 11-17.
13. Dufouil C, Alperovitch A, Ducros V, Tzourio C: Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003; 53: 214-221.
14. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483.
15. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R: Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004; 62: 1972-1976.
16. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F: Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005; 82: 636-643.
17. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, Seeman TE: Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005; 118: 161-167.
18. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R: Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2007; 85: 511-517.
19. Kivipelto M, Annerbo S, Hultdin J, Backman L, Viitanen M, Fratiglioni L, Lokk J: Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol 2009; 16: 808-813.
20. Ford AH, Flicker L, Alfonso H, Hankey GJ, Norman PE, van Bockxmeer FM, Almeida OP: Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia. J Neurol Neurosurg Psychiatry 2011; 83: 70-75.
21. Hendrie HC, Baiyewu O, Lane KA, Purnell C, Gao S, Hake A, Ogunniyi A, Gureje O, Unverzagt FW, Murrell J, Deeg MA, Hall K: Homocysteine levels and dementia risk in Yoruba and African Americans. Int Psychogeriatr 2013; 25: 1859-1866.
22. Chen C, Conklin BS, Ren Z, Zhong DS: Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J Surg Res 2002; 102: 22-30.
23. Vuckovic BA, Cabarkapa VS, Ilic TA, Salatic IR, Lozanov-Crvenkovic ZS, Mitic GP: Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients. Croat Med J 2013; 54: 480-488.
24. Herrmann W, Herrmann M, Obeid R: Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 2007; 8: 17-31.
25. Kuszczyk M, Gordon-Krajcer W, Lazarewicz JW: Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau. Neurochem Int 2009; 55: 174-180.
26. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H: Homocysteinelowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 2010; 5:e12244.
27. Connelly PJ, Prentice NP, Cousland G, Bonham J: A randomised double-blind placebocontrolled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry 2008; 23: 155-160.
28. Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351-1355.